中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis

文献类型:期刊论文

作者Li, Jing-Jing3; Yin, Hong-Kun3; Guan, Dong-Xian3; Zhao, Jiang-Sha3; Feng, Yu-Xiong3; Deng, Yue-Zhen3; Xie, Dong3; Wang, Xiang4; Bao, Ying4; Li, Nan1
刊名BRITISH JOURNAL OF CANCER
出版日期2018
卷号118期号:10页码:1337-1348
关键词snoRNA cancer type Monte Carlo feature selection support vector machine RIPPER algorithm
ISSN号0007-0920
DOI10.1038/s41416-018-0077-y
文献子类Article
英文摘要BACKGROUND: Chemerin, a known chemoattractant, participates in multiple biological events. However, its role in cancer remains largely unknown. METHODS: Chemerin expression was evaluated by real-time PCR, western blot and immunohistochemistry. Forced expression, RNAi, immunoprecipitation, etc. were used in function and mechanism study. Mouse models of extrahepatic and intrahepatic metastasis were employed to evaluate the therapeutic potential of chemerin. RESULTS: Chemerin expression was significantly downregulated in hepatocellular carcinoma, and associated with poor prognosis of HCC patients. Forced expression of chemerin inhibited in vitro migration, invasion and in vivo metastasis of HCC cells. Administration of chemerin effectively suppressed extrahepatic and intrahepatic metastases of HCC cells, resulting in prolonged survival of tumour-bearing nude mice. Chemerin upregulated expression and phosphatase activity of PTEN by interfering with PTEN-CMKLR1 interaction, leading to weakened ubiquitination of PTEN and decreased p-Akt (Ser473) level, which was responsible for suppressed migration, invasion and metastasis of HCC cells. Positive correlation between chemerin and PTEN, and reverse correlation between chemerin and p-Akt (Ser473) were also observed in HCC clinical samples and intrahepatic mouse model in vivo. CONCLUSIONS: Our study has revealed the suppressive role and therapeutic potential of chemerin in HCC metastasis, providing both a prognostic marker and drug candidate for HCC.
学科主题Oncology
WOS关键词DENDRITIC CELLS ; DOWN-REGULATION ; IN-VIVO ; EXPRESSION ; UBIQUITINATION ; ESTABLISHMENT ; STIMULATION ; MACROPHAGES ; PROGNOSIS ; SURVIVAL
语种英语
WOS记录号WOS:000435643400009
出版者NATURE PUBLISHING GROUP
版本出版稿
源URL[http://202.127.25.144/handle/331004/643]  
专题中国科学院上海生命科学研究院营养科学研究所
作者单位1.Second Mil Med Univ, Eastern Hepatobililary Surg Hosp, 225 Changhai Rd, Shanghai 200433, Peoples R China;
2.ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China,
3.Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr Metab & Food Safety, 320 Yueyang Rd, Shanghai 200031, Peoples R China;
4.Huzhou Univ, Peoples Hosp Affiliated 1, Dept Surg, Huzhou 313000, Peoples R China;
5.Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA;
推荐引用方式
GB/T 7714
Li, Jing-Jing,Yin, Hong-Kun,Guan, Dong-Xian,et al. Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis[J]. BRITISH JOURNAL OF CANCER,2018,118(10):1337-1348.
APA Li, Jing-Jing.,Yin, Hong-Kun.,Guan, Dong-Xian.,Zhao, Jiang-Sha.,Feng, Yu-Xiong.,...&,.(2018).Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.BRITISH JOURNAL OF CANCER,118(10),1337-1348.
MLA Li, Jing-Jing,et al."Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis".BRITISH JOURNAL OF CANCER 118.10(2018):1337-1348.

入库方式: OAI收割

来源:上海营养与健康研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。